Prescription Medicine

Oncology

Content filter:

All Lung Cancer Head&Neck Colorectal Cancer Oncology

Information for

General Information Patients & Carers Health Care Professional in the US Health Care Professional outside the US Journalists Jobseekers

PRESS RELEASE 25 Apr 2018 at 13:30

Boehringer Ingelheim R&D pushes to transcend disease boundaries

Read moreon
Boehringer Ingelheim R&D pushes to transcend disease boundaries
- Cancer Immunology Innovation Approach
PRESS RELEASE 04 Apr 2018 at 18:00

New Immuno-Oncology Partnership with OSE Immunotherapeutics to Develop a Pioneering Checkpoint Inhibitor

Read moreon
New Immuno-Oncology Partnership with OSE Immunotherapeutics to Develop a Pioneering Checkpoint Inhibitor
PRESS RELEASE 13 Mar 2018 at 14:00

Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer

Read moreon
Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer
PRESS RELEASE 30 Oct 2017 at 14:00

Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy

Read moreon
Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy
- Press_release_card_lung_cancer.jpg
PRESS RELEASE 09 Feb 2017 at 14:27

Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung

Read moreon
Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung
- Press_release_card_lung_cancer.jpg
PRESS RELEASE 08 Nov 2016 at 09:30

New European study highlights differing priorities in physician’s therapy goals when treating advanced lung cancer patients

Read moreon
New European study highlights differing priorities in physician’s therapy goals when treating advanced lung cancer patients
PRESS RELEASE 09 Oct 2016 at 08:15

Overall survival data from LUX-Lung 7 head-to-head trial of afatinib versus gefitinib presented at ESMO 2016

Read moreon
Overall survival data from LUX-Lung 7 head-to-head trial of afatinib versus gefitinib presented at ESMO 2016
PRESS RELEASE 09 Oct 2016 at 08:15

Phase III nintedanib trial results in patients with metastatic colorectal cancer announced at ESMO 2016

Read moreon
Phase III nintedanib trial results in patients with metastatic colorectal cancer announced at ESMO 2016
PRESS RELEASE 29 Sep 2016 at 14:00

Boehringer Ingelheim and Sarah Cannon Research Institute launch strategic collaboration to develop novel immune-oncology therapies

Read moreon
Boehringer Ingelheim and Sarah Cannon Research Institute launch strategic collaboration to develop novel immune-oncology therapies
- Electron micrograph of VSV-GP
PRESS RELEASE 28 Sep 2016 at 14:00

BOEHRINGER INGELHEIM BOOSTS IMMUNE-ONCOLOGY PIPELINE THROUGH COLLABORATION WITH VIRATHERAPEUTICS

Read moreon
BOEHRINGER INGELHEIM BOOSTS IMMUNE-ONCOLOGY PIPELINE THROUGH COLLABORATION WITH VIRATHERAPEUTICS
- Laboratory equipment
PRESS RELEASE 01 Sep 2016 at 15:00

Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE immuno-oncology drug for multiple myeloma

Read moreon
Amgen obtains global development and commercial rights from Boehringer Ingelheim for investigational BiTE immuno-oncology drug for multiple myeloma
- R&D_017.jpg
PRESS RELEASE 14 Jul 2016 at 11:00

Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines

Read moreon
Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines
- Breat_cancer_fotolia
PRESS RELEASE 13 Jul 2016 at 14:00

Boehringer Ingelheim and Lilly Announce Clinical Trial Collaboration in Metastatic Breast Cancer

Read moreon
Boehringer Ingelheim and Lilly Announce Clinical Trial Collaboration in Metastatic Breast Cancer
PRESS RELEASE 30 Mar 2016 at 10:00

Boehringer Ingelheim Venture Fund invests in Amal Therapeutics to develop novel therapeutic colorectal cancer vaccine

Read moreon
Boehringer Ingelheim Venture Fund invests in Amal Therapeutics to develop novel therapeutic colorectal cancer vaccine
PRESS RELEASE 02 Dec 2015 at 14:15

Boehringer Ingelheim and MD Anderson join forces

Read moreon Boehringer Ingelheim and MD Anderson join forces
PRESS RELEASE 12 Oct 2015 at 04:30

Boehringer Ingelheim and Philogen partner on AML

Read moreon Boehringer Ingelheim and Philogen partner on AML
PRESS RELEASE 28 Jul 2015 at 14:22

Boehringer Ingelheim and Hanmi developing EGFR TKI

Read moreon Boehringer Ingelheim and Hanmi developing EGFR TKI
PRESS RELEASE 21 May 2015 at 18:12

Eureka Therapeutics Inc. and Boehringer Ingelheim Announce a Collaboration to Identify Next Generation Antibodies for Cancer Treatment

Read moreon Eureka Therapeutics Inc. and Boehringer Ingelheim Announce a Collaboration to Identify Next Generation Antibodies for Cancer Treatment
PRESS RELEASE 14 Jan 2015 at 12:00

Boehringer Ingelheim and Vanderbilt join forces to develop new Ras inhibitors for cancer treatment

Read moreon Boehringer Ingelheim and Vanderbilt join forces to develop new Ras inhibitors for cancer treatment
PRESS RELEASE 18 Sep 2014 at 18:28

Boehringer Ingelheim and CureVac collaboration

Read moreon Boehringer Ingelheim and CureVac collaboration